Rx (Prescription Medicine)
USD $ 120.00
Fulvest 250mg 注射液是一种用于治疗激素受体阳性、HER2阴性晚期或转移性乳腺癌的药物，适用于绝经后妇女。其活性成分为 Fulvestrant，属于选择性雌激素受体降解剂（SERD）。Fulvestrant 通过阻断雌激素的作用并促进乳腺癌细胞中雌激素受体的降解来发挥作用。这有助于减缓或停止雌激素依赖性肿瘤的生长。Fulvet 250mg 注射液由医护专业人员进行给药。常规剂量为 500mg（两支 250mg 注射液，分别注射于臀部），在第 0 天、第 14 天和第 28 天给药，随后每 28 天一次。常见的不良反应可能包括潮热、恶心、疲劳、注射部位反应和疼痛。如有任何潜在的不良反应，请与医生讨论。请将 Fulvet 250mg 注射液存放于室温，避光并防潮。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Strength |
其他品牌的 FULVESTRANT 250 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
